By Dr Linda Martin

Journal articles

Schwartz RJ; Ho G; Smith A; Collgros H; Regio Pereira A; Gouveia B; Long GV; Menzies AM; Potter AJ; Paver E; Star P; Scolyer RA; Martin LK, 2022, 'Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy', Journal of the European Academy of Dermatology and Venereology, 36, pp. e445 - e448, http://dx.doi.org/10.1111/jdv.17940

Teh N; Pennington V; Martin LK, 2022, '‘Home-school toes’ – a case series of paediatric perniosis presentations', Australasian Journal of Dermatology, 63, pp. 256 - 258, http://dx.doi.org/10.1111/ajd.13827

Thompson JR; Smith AL; Lo SN; Kasparian NA; Saw RPM; Dieng M; Seaman L; Martin LK; Guitera P; Milne D; Schmid H; Cust AE; Bartula I, 2022, 'Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0-II) melanoma', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2021-054337

Koutsis JJ; Cachia AR; Guitera PA; Martin LK, 2022, 'Optical coherence tomography features of a tumour of the follicular infundibulum', Australasian Journal of Dermatology, 63, pp. 133 - 135, http://dx.doi.org/10.1111/ajd.13747

Haefliger S; Guitera P; Melhoranse Gouveia B; Colebatch AJ; Scolyer RA; Rtshiladze M; Martin LK, 2021, 'Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children', Pediatric Dermatology, 38, pp. 1549 - 1552, http://dx.doi.org/10.1111/pde.14846

Martin A; Ribero S; Martin LK; Guitera P, 2021, 'Longitudinal melanonychia striata mimicking a melanoma during pregnancy', Australasian Journal of Dermatology, 62, pp. e451 - e453, http://dx.doi.org/10.1111/ajd.13590

Rogers CL; Gibson M; Kern JS; Martin LK; Robertson SJ; Daniel BS; Su JC; Murrell OGC; Feng G; Murrell DF, 2021, 'A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', Jaad International, 2, pp. 134 - 152, http://dx.doi.org/10.1016/j.jdin.2020.12.007

Rogers C; Gibson M; Kern JS; Martin LK; Robertson SJ; Su JC; Daniel BS; Murrell DF, 2021, '157 A comparison study of Outcome Measures for Epidermolysis Bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)', Journal of Investigative Dermatology, 141, pp. S28 - S28, http://dx.doi.org/10.1016/j.jid.2021.02.177

Murrell DF; Lucky AW; Salas-Alanis JC; Woodley DT; Palisson F; Natsuga K; Nikolic M; Ramirez-Quizon M; Paller AS; Lara-Corrales I; Barzegar MA; Sprecher E; Has C; Laimer M; Bruckner AL; Bilgic A; Nanda A; Purvis D; Hovnanian A; Murat-Sušić S; Bauer J; Kern JS; Bodemer C; Martin LK; Mellerio J; Kowaleski C; Robertson SJ; Bruckner-Tuderman L; Pope E; Marinkovich MP; Tang JY; Su J; Uitto J; Eichenfield LF; Teng J; Aan Koh MJ; Lee SE; Khuu P; Rishel HI; Sommerlund M; Wiss K; Hsu CK; Chiu TW; Martinez AE, 2020, 'Multidisciplinary care of epidermolysis bullosa during the COVID-19 pandemic—Consensus: Recommendations by an international panel of experts', Journal of the American Academy of Dermatology, 83, pp. 1222 - 1224, http://dx.doi.org/10.1016/j.jaad.2020.06.1023

van Baar MLM; Guminski AD; Ferguson PM; Martin LK, 2019, 'Pembrolizumab for cutaneous squamous cell carcinoma: Report of a case of inoperable squamous cell carcinoma with complete response to pembrolizumab complicated by granulomatous inflammation', Jaad Case Reports, 5, pp. 491 - 494, http://dx.doi.org/10.1016/j.jdcr.2019.04.006

Zhao CY; Hao EY; Oh DD; Daniel BS; Martin LK; Su JC; Rodrigues M; Murrell DF, 2017, 'A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients', British Journal of Dermatology, 176, pp. 985 - 992, http://dx.doi.org/10.1111/bjd.15271

Sebaratnam DF; Martin LK; Venugopal SS; Mangos G; Freiman J; de Souza P; Farnsworth A; Cheung K; Scolyer RA; Murrell DF, 2014, 'Diffuse melanosis cutis in the setting of BRAFV600E metastatic melanoma', International Journal of Dermatology, 53, pp. 1409 - 1411, http://dx.doi.org/10.1111/ijd.12614

Gray R; Ives N; Rick C; Patel S; Gray A; Jenkinson C; McIntosh E; Wheatley K; Williams A; Clarke CE; Sandercock P; Baigent C; Crome P; Abbott R; Baker M; Castleton B; Counsell C; Deb AK; Fairweather S; Fitzpatrick R; MacPhee G; Malone T; Mant D; Ming A; Morrish P; Ohri P; Pearce V; Wood B; Worth P; Au P; Boodell T; Cheed V; Daniels J; Dowling F; Edmondson A; Hawker R; Herd C; Hilken N; Kaur S; Ottridge R; Peto L; Sidile C; Tomlinson C; Tyler E; Winkles N; Kent S; Caie L; Caslake R; Coleman R; Crowley P; Gerrie L; Gordon J; Harris C; Leslie V; Macleod MA; Taylor K; Barker R; Forsyth D; Halls M; Lennox G; Young J; Azie E; Barrett J; Monaghan A; Turnbull C; Vanek H; Blake D; Manford M; Thangarajah N; Johnson M; Wallis P; Carr P; Cochrane L; Prescott R; Rose A; Drover M; Karunaratne P; McLaren A; Jones E; Nasar M; Bayliss M; Jones AP; Lewis B; Dunn A; Eckley M; Price J; Woodman G; Aldridge G; Bhuvanendran N; Lewis S; Mann C; Patel K; Ghaus N; Grueger A; Mallinson B; Wihl G; Ballantyne S; Coyle S; Hornabrook R; Hutchinson S, 2014, 'Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): A large, open-label, pragmatic randomised trial', Lancet, 384, pp. 1196 - 1205, http://dx.doi.org/10.1016/S0140-6736(14)60683-8

Sebaratnam DF; Hanna AM; Chee SN; Frew JW; Venugopal SS; Daniel BS; Martin LK; Rhodes LM; Tan JCK; Wang CQ; Welsh B; Nijsten T; Murrell DF, 2013, 'Development of a quality-of-life instrument for autoimmune bullous disease: The autoimmune bullous disease quality of life questionnaire', JAMA Dermatology, 149, pp. 1186 - 1191, http://dx.doi.org/10.1001/jamadermatol.2013.4972

Sebaratnam DF; Venugopal SS; Frew JW; McMillan JR; Finkelstein ER; Martin LK; Murrell DF, 2013, 'Diffuse melanosis cutis: a systematic review of the literature.', J Am Acad Dermatol, 68, pp. 482 - 488, http://dx.doi.org/10.1016/j.jaad.2012.08.018

Martin L; Werth VP; Villaneuva E; Murrell DF, 2011, 'A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus', Journal of the American Academy of Dermatology, 64, pp. 903 - 908, http://dx.doi.org/10.1016/j.jaad.2010.04.039

Frew JW; Martin LK; Nijsten T; Murrell DF, 2010, 'Erratum: Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument (British Journal of Dermatology (2009) 161 (1323-1330))', British Journal of Dermatology, 162, pp. 701, http://dx.doi.org/10.1111/j.1365-2133.2010.09642.x

Frew JW; Martin LK; Nijsten T; Murrell DF, 2009, 'Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument', British Journal of Dermatology, 161, pp. 1323 - 1330, http://dx.doi.org/10.1111/j.1365-2133.2009.09347.x

Figtree MC; Miyakis S; Tanaka K; Martin L; Konecny P; Krilis S, 2009, 'Dapsone hypersensitivity syndrome causing disseminated intravascular coagulation', BMJ Case Reports, http://dx.doi.org/10.1136/bcr.11.2008.1257

Sperber BR; Martin LK; Murrell DF; Werth VP, 2009, 'Pemphigus', , pp. 581 - 594, http://dx.doi.org/10.1002/9781444300161.ch58

Martin L; Russell S; Wargon O, 2009, 'Chronic localized intravascular coagulation complicating multifocal venous malformations', Australasian Journal of Dermatology, 50, pp. 276 - 280

Martin L; Werth V; Villanueva E; Segall J; Murrell DF, 2009, 'Interventions for pemphigus vulgaris and pemphigus foliaceus', Cochrane Database of Systematic Reviews, pp. 1 - 73

Agero A; Lahmar J; Holzborn R; Martin L; Freckmann M; Murrell DF, 2009, 'Naevus of Ota presenting in two generations: A mother and daughter', Journal of the European Academy of Dermatology and Vernereology, 23, pp. 102 - 104

Murrell DF; Dick S; Ahmed A; Amagai M; Barnadas M; Borradori L; Bystryn J; Cianchini G; Diaz L; Fivenson D; Hall R; Harman K; Hashimoto T; Hertl M; Hunzelmann N; Iranzo P; Joly P; Jonkman M; Kitajima Y; Korman N; Martin L; Mimouni D; Pandya A; Payne A; Rubenstein D; Shimizu H; Sinha A; Sirois D; Zillikens D; Werth V, 2008, 'Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus', Journal of the American Academy of Dermatology, 58, pp. 1043 - 1046, http://dx.doi.org/10.1016/j.jaad.2008.01.012

Frew J; Martin L; Murrell DF, 2008, 'Development of a quality of life measure specific for epidermolysis bullosa', Journal of Investigative Dermatology, 128, pp. S80 - S80

Martin LE; Rubin A; Theocharous C; Murrell DF, 2008, 'Podophyllin reaction mimicking Bowen`s disease in a patient with delusions of verrucosis', Clinical and Experimental Dermatology, 33, pp. 443 - 445, http://dx.doi.org/10.1111/j.1365-2230.2007.02668.x

Frew J; Martin L; Murrell DF, 2008, 'Quality of life evaluation in epidermolysis bullosa', Journal of the American Academy of Dermatology, 58, pp. AB81 - AB81

Frew J; Martin L; Murrell DF, 2008, 'Quality of life evaluation in epidermolysis bullosa: Development of the QOLEB questionnaire', Journal of Investigative Dermatology, 128, pp. 1607 - 1607

Martin LE; Kossard S; Murrell DF, 2008, 'Reticular variant of mid-dermal elastolysis', American Journal of Dermatopathology, 30, pp. 287 - 290

Murrell DF; Martin L, 2008, 'Treatment of pemphigus - The need for more evidence', Archives of Dermatology, 144, pp. 100 - 101

Martin L; Lawrence R; Kossard S; Murrell DF, 2007, 'Cutaneous Mycobacterium neoaurum infection causing scarring alopecia in an immunocompetent host', British Journal of Dermatology, 157, pp. 204 - 206

Martin L; Sturgess AD; Sillence D; Murrell DF, 2007, 'Fabry disease in a heterozygote presenting as hand ischaemia and painful acroparaesthesia', Australasian Journal of Dermatology, 48, pp. 40 - 42

Martin L; Wittal R; Murrell DF; Le Guay J, 2007, 'Randomised controlled trial of minigrafting versus recell in stable vitiligo', Journal of Investigative Dermatology, 127, pp. 2685 - 2685

Martin L; Yiasemides E; Trisnowati N; Su J; Klingberg S; Marr PJ; Orchard D; Varigos G; Murrell DF, 2007, 'Recessive epidermolysis bullosa simplex due to a homozygous truncation mutation KRT14 Y204X with basal K6/16 expression and an ameliorating phenotype', Journal of Investigative Dermatology, 127, pp. 2690 - 2690

Martin L; Rubin A; Tran K; Pas H; Marr P; Edmonds J; Murrell D, 2006, 'A complicated blistering disease case demonstrating the usefulness of immunoblotting and ELISA for the diagnosis of immunobullous diseases', Australasian Journal of Dermatology, 47, http://dx.doi.org/10.1111/j.1440-0960.2006.00311_3.x

Martin L; Werth V; Agero A; Villaneuva E; Segall J; Murrell DF, 2006, 'Interventions for pemphigus vulgaris and pemphigus foliaceus', Cochrane Database of Systematic Reviews, pp. 1 - 16

Martin L; Murrell DF, 2005, 'Gorlin`s Syndrome', Medical Observer, June 2005, pp. 30 - 30

Martin L; Sturgess AD; Murrell DF, 2005, 'Heterozygote for Fabry`s disease presents with hand ischaemia and painful acroparathaesia', Australasian Journal of Dermatology, 46, pp. A18 - A19

Martin L; Fischer A; Murrell DF, 2005, 'Porokeratosis', Medical Observer

Boersma A; Pas H; Kloosterhuis G; Kemp MW; Kossard S; Martin LE; Murrell DF; Jonkman M, 2005, 'The preparation of dermal and epidermal protein extracts for the detection of autoimmune bullous disorders using an immunoblotting technique', Journal of Investigative Dermatology, 125, pp. A12 - A12

Ritchie AG; Fung AT; Fox PN; Roberts KE; Vedelago JS; Blake RC; Saber AA; Glass JM; Martin LK, 2002, 'The Medical Students' Aid Project: Building partnerships with the developing world', Medical Journal of Australia, 177, pp. 641 - 643, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04995.x

Back to profile page